Data analysis Puts PACE Chronic Fatigue Syndrome Trial on Slippery Slope to Retraction
The issue at stake was a big one. It asked whether changes to the original protocol of the PACE trial ended up stacking the deck. It was easy to see how they might have; some of the recovery criteria were so weird as to seem ridiculous. The changes in the studies...
“A Nation in Pain: Healing Our Biggest Health Problem” – A Review
Chronic pain costs more than heart disease, cancer and diabetes combined yet gets a fraction of their funding. Judy Foreman knows well the cost of our medical systems dysfunctional approach to pain. A medical journalist used to good medical care, she was dismayed by...
Ampligen Takes Big Step Forward – Becomes First Drug Approved Anywhere For Chronic Fatigue Syndrome
Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in...
Iron Man: A Young Person’s POTS ME/CFS Recovery Story
Infection Fells Teenager In August 2014, a formerly very healthy and active Jack Schlanger entered the realm of the chronically ill. The thirteen-year-old’s story began with three days of high fever followed by eight days of lower-grade fever and extreme...
When Retreat Means Advance: A Recovered Chronic Fatigue Syndrome/Fibromyalgia Patient Looks Back
Recovered ME/CFS/Fibromyalgia patient discusses urge during illness and how this looks like the body's road to recovery & healing.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
